Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report

Classic Kaposi's sarcoma (KS) is a disease with low mortality but high morbidity. The optimum treatment of KS depends upon several factors, including location of lesions, disease progression, severity of symptoms and patient preference. We report the long-term response to the use of intralesion...

Full description

Bibliographic Details
Main Authors: Yasir Azim Mirza, Davide Altamura, Torkan Hirbod, Roberto Verdolini
Format: Article
Language:English
Published: Karger Publishers 2015-02-01
Series:Case Reports in Dermatology
Subjects:
Online Access:http://www.karger.com/Article/FullText/369490
_version_ 1828492730471284736
author Yasir Azim Mirza
Davide Altamura
Torkan Hirbod
Roberto Verdolini
author_facet Yasir Azim Mirza
Davide Altamura
Torkan Hirbod
Roberto Verdolini
author_sort Yasir Azim Mirza
collection DOAJ
description Classic Kaposi's sarcoma (KS) is a disease with low mortality but high morbidity. The optimum treatment of KS depends upon several factors, including location of lesions, disease progression, severity of symptoms and patient preference. We report the long-term response to the use of intralesional doxorubicin to successfully treat a large cutaneous lesion of KS on a patient refractory to traditional treatments.
first_indexed 2024-12-11T11:25:43Z
format Article
id doaj.art-df8ec8ce0db14b3bab4d4f45b3c09d4f
institution Directory Open Access Journal
issn 1662-6567
language English
last_indexed 2024-12-11T11:25:43Z
publishDate 2015-02-01
publisher Karger Publishers
record_format Article
series Case Reports in Dermatology
spelling doaj.art-df8ec8ce0db14b3bab4d4f45b3c09d4f2022-12-22T01:09:01ZengKarger PublishersCase Reports in Dermatology1662-65672015-02-0171171910.1159/000369490369490Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case ReportYasir Azim MirzaDavide AltamuraTorkan HirbodRoberto VerdoliniClassic Kaposi's sarcoma (KS) is a disease with low mortality but high morbidity. The optimum treatment of KS depends upon several factors, including location of lesions, disease progression, severity of symptoms and patient preference. We report the long-term response to the use of intralesional doxorubicin to successfully treat a large cutaneous lesion of KS on a patient refractory to traditional treatments.http://www.karger.com/Article/FullText/369490Kaposiߣs sarcomaIntralesional doxorubicinTreatmentClassic Kaposiߣs sarcoma
spellingShingle Yasir Azim Mirza
Davide Altamura
Torkan Hirbod
Roberto Verdolini
Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
Case Reports in Dermatology
Kaposiߣs sarcoma
Intralesional doxorubicin
Treatment
Classic Kaposiߣs sarcoma
title Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
title_full Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
title_fullStr Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
title_full_unstemmed Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
title_short Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
title_sort long term response of classic kaposi s sarcoma to intralesional doxorubicin a case report
topic Kaposiߣs sarcoma
Intralesional doxorubicin
Treatment
Classic Kaposiߣs sarcoma
url http://www.karger.com/Article/FullText/369490
work_keys_str_mv AT yasirazimmirza longtermresponseofclassickaposissarcomatointralesionaldoxorubicinacasereport
AT davidealtamura longtermresponseofclassickaposissarcomatointralesionaldoxorubicinacasereport
AT torkanhirbod longtermresponseofclassickaposissarcomatointralesionaldoxorubicinacasereport
AT robertoverdolini longtermresponseofclassickaposissarcomatointralesionaldoxorubicinacasereport